N. Iwamoto et al. (2016) [nSMOL]
Fully validated LCMS bioanalysis of Bevacizumab in human plasma using nano-surface and molecular-orientation limited (nSMOL) proteolysis
Drug Metab. Pharmacokinet., 31, 46 (2016).
Fully validated LCMS bioanalysis of Bevacizumab in human plasma using nano-surface and molecular-orientation limited (nSMOL) proteolysis
Drug Metab. Pharmacokinet., 31, 46 (2016).
PAGE TOP